Research

Dr. Andrea Facciabene's lab is focused on immunotherapy and investigation of the network of immune responses to tumors, combining basic research and clinical investigation. The gut microbiome is increasingly recognized as a major player in both malignant progression and response to treatment. The Facciabene lab aims to advance the understanding of this new player and Bridging Radiation Therapy in the context of the CAR T cell approach and to implement the new findings to improve the anti-tumor effects of cellular therapies.